Notice Type
Departmental
Notice Title

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Evrysdi
Active Ingredient: Risdiplam 0.75mg/mL
Dosage Form: Powder for oral solution
New Zealand Sponsor: Roche Products (NZ) Limited
Manufacturer: F Hoffmann-La Roche Limited, Basel, Switzerland
   
Product: Optifix
Active Ingredient: Naphazoline hydrochloride 0.1%w/v
Dosage Form: Eye drops, solution
New Zealand Sponsor: Pharmabroker Sales Limited
Manufacturer: Bruschettini S.R.L., Genova, Italy
   
Product: Scholl Clotrimazole Athlete’s Foot Cream
Active Ingredient: Clotrimazole 10mg/g
Dosage Form: Topical cream
New Zealand Sponsor: Reckitt Benckiser (New Zealand) Limited
Manufacturer: PSM Healthcare Limited trading as API Consumer Brands, Auckland, New Zealand
   
Product: Ticagrelor Sandoz
Active Ingredient: Ticagrelor 60mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: PharOS MT Limited, Birzebbugia, Malta
   
Product: Ticagrelor Sandoz
Active Ingredient: Ticagrelor 90mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: PharOS MT Limited, Birzebbugia, Malta


Dated this 20th day of January 2022.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).